EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a genetic test spare young breast cancer patients from chemo?
Disease control Not yet recruitingThis study looks at whether a genetic test (Prosigna®) can help decide if younger women with a common type of early breast cancer need chemotherapy. About 3380 premenopausal women will be randomly assigned to either standard treatment (always chemo plus hormone therapy) or a test…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 16, 2026 23:35 UTC
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Not yet recruitingThis study tests a new drug combination (SHR-A1811 plus pertuzumab) given before surgery for women with early or locally advanced HR-positive, HER2-positive breast cancer. The goal is to see if this treatment can eliminate all signs of cancer in the breast and lymph nodes at the …
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for breast cancer patients who Can't tolerate standard hormone pills
Disease control Not yet recruitingThis study is for people with early-stage, hormone-sensitive breast cancer who had to stop their usual hormone therapy due to side effects. It tests a new drug called giredestrant to see if it is easier to tolerate and still helps control the cancer. About 300 postmenopausal wome…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
100,000 breast cancer patients studied to predict return of disease
Knowledge-focused Not yet recruitingThis study will look back at medical records of 100,000 people in Korea who had early-stage hormone receptor-positive, HER2-negative breast cancer and received surgery. The goal is to learn how often the cancer comes back and what factors might increase that risk. No new treatmen…
Matched conditions: EARLY BREAST CANCER
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:36 UTC
-
Real-World data may reveal best Follow-Up for tough breast cancers
Knowledge-focused Not yet recruitingThis study looks back at medical records of 2,000 people with HER2-positive breast cancer who still had cancer after initial treatment and surgery. Researchers compare two different drug combinations given after surgery to see which one helps prevent the cancer from coming back. …
Matched conditions: EARLY BREAST CANCER
Sponsor: Hebei Medical University Fourth Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC
-
Breast cancer pill study: do patients stick with it?
Knowledge-focused Not yet recruitingThis study tracks 81 patients with early-stage, hormone-positive breast cancer who are prescribed a two- to three-year course of CDK4/6 inhibitor pills (abemaciclib or ribociclib) after surgery. The goal is to see how many stop taking the pills early and why. Researchers hope to …
Matched conditions: EARLY BREAST CANCER
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC